Sign in

NCT06678490Active, not recruiting

Support C Post-Market Registry

PMCF Registry Study Paclitaxel-eluting Balloon Catheter Support C

Source: ClinicalTrials.gov · Last updated 10 Feb 2026

Brief summary (registry, in English)

To collect post marketing surveillance data on consecutive patients with coronary heart disease intended to be or treated by the drug eluting Support C PTCA balloon catheter when used according to the Instructions for Use. Data will be collected in order to assess the long term safety and performance of the Support C Drug Coated Balloon (DCB) in routine clinical practice.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
282 (actual)
First submitted
6 Nov 2024
Start date
9 Jul 2025
Primary completion date
28 Feb 2027
Lead sponsor
OrbusNeich
NCT number
NCT06678490

What you commit to

  • Study type: Observational
  • Participants enrolled: 282
  • From 9 Jul 2025 to the primary completion date, 28 Feb 2027
  • 12 sites in 4 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients are excluded if ANY of the following additional conditions apply:
    • High probability of non-adherence to the follow-up requirements (due to social, psychological or medical reasons)
    • Currently participating in another investigational drug or device study in which a routine angiographic follow-up is planned
    • A life expectancy of \<1year
    • Explicit refusal of participation in the registry

Who the study is looking for

  • Consecutive patients intended to be, or treated by Support C DCB as per physicians' decision and according to Instructions for Use (IFU) in the setting of routine clinical care are entered into the registry.
    • Note:
  • In case of major dissection requiring bailout stenting after DCB use the patients will be included in the registry and followed as per study schedule.
  • If major dissection occurred after lesion preparation, but before DCB use and lesion was stented, the patient will not be included in the registry.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (12)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Krajská nemocnice Liberec
Coordinator of this site? Confirm its status		LiberecCzechiaUnknown status
Motol University Hospital
Coordinator of this site? Confirm its status		PragueCzechiaUnknown status
Katholischen Krankenhaus "St. Johann Nepomuk"
Coordinator of this site? Confirm its status		ErfurtGermanyUnknown status
Evangelisches Krankenhaus Hagen-Haspe gGmbH
Coordinator of this site? Confirm its status		HagenGermanyUnknown status
MediClin Herzzentrum Lahr
Coordinator of this site? Confirm its status		LahrGermanyUnknown status
Martha Maria Nürnberg
Coordinator of this site? Confirm its status		NurembergGermanyUnknown status
Hospital de la Santa Creu i Sant Pau
Coordinator of this site? Confirm its status		BarcelonaSpainUnknown status
Hospital Universitario Lucus Augusti
Coordinator of this site? Confirm its status		LugoSpainUnknown status
Hospital Universitario de la Princesa
Coordinator of this site? Confirm its status		MadridSpainUnknown status
Hospital Universitario Virgen de la Arrixaca
Coordinator of this site? Confirm its status		MurciaSpainUnknown status
Hospital Universitario Virgen del Rocio
Coordinator of this site? Confirm its status		SevilleSpainUnknown status
National Heart Institute (Institut Jantung Negara)
Coordinator of this site? Confirm its status		Kuala LumpurMalaysiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.